Viemed Healthcare, Inc. (VMD) Stock Forecast
Data as of Sep 21, 2026Healthcare · Current price $8.91 (-0.17%)
Consensus Target
$14.00
Upside
+56.7%
Analysts
1
Rating
Hold(3.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Hold
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
VMD vs Sector & Market
| Metric | VMD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.25 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +56.7% | +22243.7% | +21.5% |
| P/E Ratio | 24.11 | 3.74 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $80M | $80M | $81M | 1 |
| 2026-12-31 | $83M | $83M | $83M | 1 |
| 2027-03-31 | $85M | $85M | $85M | 1 |
| 2027-06-30 | $88M | $89M | $89M | 1 |
| 2027-09-30 | $93M | $93M | $93M | 1 |
| 2027-12-31 | $96M | $97M | $97M | 1 |
| 2028-12-31 | $416M | $416M | $416M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.12 | $0.13 | $0.13 | 1 |
| 2026-12-31 | $0.14 | $0.14 | $0.15 | 1 |
| 2027-03-31 | $0.13 | $0.13 | $0.13 | 1 |
| 2027-06-30 | $0.15 | $0.15 | $0.15 | 1 |
| 2027-09-30 | $0.15 | $0.15 | $0.15 | 1 |
| 2027-12-31 | $0.17 | $0.17 | $0.17 | 1 |
| 2028-12-31 | $0.85 | $0.85 | $0.85 | 1 |
Frequently Asked Questions
What is the analyst consensus for VMD?
The consensus among 1 analysts covering Viemed Healthcare, Inc. (VMD) is Hold with an average price target of $14.00.
How many analysts cover VMD?
1 analysts have issued ratings for Viemed Healthcare, Inc. in the past 12 months.
Is VMD a buy or sell right now?
Based on 1 analyst ratings, VMD has a consensus rating of Hold (3.00/5) with a +56.7% upside to the consensus target of $14.00.
What are the earnings estimates for VMD?
Analysts estimate VMD will report EPS of $0.13 for the period ending 2026-09-30, with revenue estimated at $80M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.